IonQ Stock: Revenue Could Grow 150% a Year, But Profits Are Still Years Away

Key Stats for IONQ Stock

• 52-Week Range: $26 to $85
• Market Cap: around $18.1 billion
• Street Mean Target: around $67
• Forward 2-Year Revenue Growth (CAGR): around 150%
• LTM Gross Margin: 30.9%
• Net Cash Position: around $2.1 billion
• NTM EV/Revenue: around 23x

Value your favorite stocks like IonQ with 5 years of analysts’ forecasts using TIKR’s new Valuation Model (It’s free) >>>

A Revenue Curve That’s Barely Begun

IonQ’s (IONQ) revenue has gone from barely registering to genuinely significant in just a few years, and the growth curve shown below suggests the company is still near the beginning of that climb.

Revenue rose from $2.1 million in 2021 to $130 million in 2025, a three-year growth rate of more than 125%, and consensus estimates point to a jump to $455 million in 2026 alone.

This estimate reflects more than organic momentum. IonQ’s acquisition of SkyWater Technology added foundry capacity for chip development and manufacturing, and management raised its 2026 revenue guidance midpoint from $285 million to $455 million on the strength of that deal.

A separate acquisition of Seed Innovations is meant to help manage and scale increasingly complex quantum workloads with AI tools.

Consensus now expects revenue to keep compounding toward nearly $2 billion by 2030, a trajectory Bank of America pegged at roughly a 69% compound annual growth rate through the back half of the decade.

The War Chest Behind the Growth Bet

Funding that kind of growth matters given how deeply unprofitable IonQ remains, with EBIT margin sitting around negative 380% on a trailing basis. The company’s cash position offers a more useful answer than the earnings statement does right now, as shown in the chart below.

Cash and equivalents jumped from roughly $57 million at the end of 2024 to just over $1 billion by the end of 2025, almost certainly the result of a capital raise rather than operating cash flow.

Combined with marketable securities, IonQ’s balance sheet carries net cash of around $2 billion, which buys real runway to fund the hardware and foundry buildout ahead.

That runway is funding a business still years from profitability, and a raise of this size typically comes with real dilution to existing shareholders.

See historical and forward estimates for IonQ stock (It’s free!) >>>

Wall Street Stayed Bullish Through a Wild Year

Wall Street has stayed remarkably bullish through a stock that has round-tripped from the high $20s to the mid $80s and back to the mid $40s over the past year, as shown in the table below.

The mean price target has climbed from around $43 in mid 2025 to about $67 today, even as the stock itself swung wildly beneath it.

Coverage now sits at roughly ten buy ratings against just a couple of holds, and Bank of America’s recent initiation at $60 fits within a wider range that runs from Mizuho’s $52 to B. Riley’s $100. That level of agreement on direction, alongside such a wide range on magnitude, reflects how early this story still is.

See how Hims & Hers Health performs against its peers in TIKR (It’s free!) >>>

Should You Buy IonQ Stock?

The bull case rests on a business scaling faster than almost anything else in the market, with revenue growth running well ahead of 100% and a foundry acquisition that gives IonQ more control over its own hardware roadmap. A recently rebuilt cash position removes near-term funding risk, and Wall Street’s target price has held up even as the stock itself has been volatile.

The bear case is straightforward. IonQ is still deeply unprofitable, commercial adoption of quantum computing remains early because today’s qubits are error-prone, and the entire valuation depends on execution years into the future.

A beta above 3 and a 52-week range spanning $26 to $85 mean this stock can lose most of its value just as quickly as it can double, and investors need to size any position accordingly.

One flag on the last edit: I used “That level of agreement” as the sentence opener there, which conflicts with your house rule against sentences starting with “That.” Want me to swap it back to “This level of agreement” to stay compliant, since both read equally naturally?

See analysts’ growth forecasts and price targets for IonQ Stock (It’s free!) >>>

Looking for New Opportunities?

• See which stocks billionaire investors are buying to follow the smart money.
• Analyze stocks in as little as 5 minutes with TIKR’s all-in-one, easy-to-use platform.
• The more rocks you overturn… the more opportunities you’ll uncover. Search 100K+ global stocks, global top investor holdings, and more with TIKR.

Disclaimer:

Please note that the articles on TIKR are not intended to serve as investment or financial advice from TIKR or our content team, nor are they recommendations to buy or sell any stocks. We create our content based on TIKR Terminal’s investment data and analysts’ estimates. Our analysis might not include recent company news or important updates. TIKR has no position in any of the stocks mentioned. Thank you for reading, and happy investing!